Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biochim Biophys Acta ; 1834(10): 2089-96, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23871879

ABSTRACT

The phosphodiesterase-4 (PDE4) enzyme is a promising therapeutic target for several diseases. Our previous studies found resveratrol and moracin M to be natural PDE4 inhibitors. In the present study, three natural resveratrol analogs [pterostilbene, (E)-2',3,5',5-tetrahydroxystilbene (THSB), and oxyresveratrol] are structurally related to resveratrol and moracin M, but their inhibition and mechanism against PDE4 are still unclear. A combined method consisting of molecular docking, molecular dynamics (MD) simulations, binding free energy, and bioassay was performed to better understand their inhibitory mechanism. The binding pattern of pterostilbene demonstrates that it involves hydrophobic/aromatic interactions with Phe340 and Phe372, and forms hydrogen bond(s) with His160 and Gln369 in the active site pocket. The present work also reveals that oxyresveratrol and THSB can bind to PDE4D and exhibits less negative predicted binding free energies than pterostilbene, which was qualitatively validated by bioassay (IC50=96.6, 36.1, and 27.0µM, respectively). Additionally, a linear correlation (R(2)=0.953) is achieved for five PDE4D/ligand complexes between the predicted binding free energies and the experimental counterparts approximately estimated from their IC50 values (≈RT ln IC50). Our results imply that hydrophobic/aromatic forces are the primary factors in explaining the mechanism of inhibition by the three products. Results of the study help to understand the inhibitory mechanism of the three natural products, and thus help the discovery of novel PDE4 inhibitors from resveratrol, moracin M, and other natural products.


Subject(s)
Cyclic Nucleotide Phosphodiesterases, Type 3/chemistry , Phosphodiesterase 4 Inhibitors/chemistry , Plant Extracts/chemistry , Stilbenes/chemistry , Binding Sites , Biological Assay , Cyclic Nucleotide Phosphodiesterases, Type 4 , Humans , Hydrogen Bonding , Hydrophobic and Hydrophilic Interactions , Kinetics , Molecular Docking Simulation , Molecular Dynamics Simulation , Plant Extracts/isolation & purification , Protein Binding , Protein Structure, Tertiary , Resveratrol , Stilbenes/isolation & purification , Structure-Activity Relationship , Thermodynamics
2.
Article in English | MEDLINE | ID: mdl-22750860

ABSTRACT

Feruloyl esterase cleaves the ester linkage formed between ferulic acid and polysaccharides in plant cell walls and thus has wide potential industrial applications. A novel feruloyl esterase (EstF27) identified from a soil metagenomic library was crystallized and a complete data set was collected from a single cooled crystal using an in-house X-ray source. The crystal diffracted to 2.9 Šresolution and belonged to space group P2(1)2(1)2(1), with unit-cell parameters a = 94.35, b = 106.19, c = 188.51 Å, α = ß = γ = 90.00°. A Matthews coefficient of 2.55 Å(3) Da(-1), with a corresponding solvent content of 51.84%, suggested the presence of ten protein subunits in the asymmetric unit.


Subject(s)
Carboxylic Ester Hydrolases/chemistry , Crystallization , Crystallography, X-Ray , Metagenomics , Soil
3.
Bioorg Med Chem Lett ; 22(9): 3261-4, 2012 May 01.
Article in English | MEDLINE | ID: mdl-22483586

ABSTRACT

Phosphodiesterase-4 (PDE4) has been identified to be a promising target for treatment of asthma. Moracin M extracted from Chinese herbal drug 'Sang-Bai-Pi' (Morus alba L.) was studied for the inhibitory affinity towards PDE4. It inhibited PDE4D2, PDE4B2, PDE5A1, and PDE9A2 with the IC(50) values of 2.9, 4.5, >40, and >100 µM, respectively. Our molecular docking and 8ns molecular dynamics (MD) simulations demonstrated that moracin M forms three hydrogen bonds with Gln369, Asn321, and Asp318 in the active site and stacks against Phe372. In addition, comparative kinetics analysis of its analog moracin C was carried out to qualitatively validate their inhibitory potency as predicted by the binding free energy calculations after MD simulations.


Subject(s)
Benzofurans/pharmacology , Morus/chemistry , Phosphodiesterase 4 Inhibitors/chemistry , Resorcinols/pharmacology , Computer Simulation , Drugs, Chinese Herbal , Inhibitory Concentration 50 , Kinetics , Molecular Dynamics Simulation , Phosphodiesterase 4 Inhibitors/isolation & purification , Plant Extracts/chemistry , Plant Extracts/pharmacology , Protein Binding
SELECTION OF CITATIONS
SEARCH DETAIL
...